• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

REKA:IT

1,010.00 ILs 46.00 4.36%

As of 11:24:43 ET on 10/30/2014.

Snapshot for Rekah (REKA)

Open: 1,068.00 Day's Range: 1,000.00 - 1,068.00 Volume: 44,365
Previous Close: 1,056.00 52wk Range: 1,000.00 - 1,800.00 1-Yr Rtn: -27.13%

Stock Chart for REKA

No chart data available.
  • REKA:IT 1,014.00
  • 1D
  • 1M
  • 1Y
1,056.00
Interactive REKA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for REKA

Current P/E Ratio (ttm) 8.4858
Estimated P/E(-) -
Relative P/E vs. TA-100 0.5275
Earnings Per Share (ttm) 1.1902
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 56.29
Shares Outstanding (M) 5.57
30 Day Average Volume 7,654
Price/Book (mrq) 0.6943
Price/Sale (ttm) 0.2092
Dividend Indicated Gross Yield -%
Cash Dividend (ILs) 30.0000
Dividend Ex-Date 06/11/2007
5 Year Dividend Growth -
Next Earnings Announcement 11/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for REKA

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for REKA

Rekah Pharmaceutical Industry Ltd. manufactures medicines, vitamins, and food additives. The Company produces tablets, ointments, syrups, creams, and suppositories.

Mordechai AlgrablyChairmanGiorget AlgrablyChief Executive Officer
Yuval AlgrablyDeputy CEOChaim CohenChief Accounting Officer
More Company Profile & Key Executives for REKA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil